Montironi R - Search Results

1

Precancerous lesions and conditions of the prostate: from morphological and biological characterization to chemoprevention.

Montironi R, Mazzucchelli R, Scarpelli M. Montironi R, et al. Ann N Y Acad Sci. 2002 Jun;963:169-84. doi: 10.1111/j.1749-6632.2002.tb04108.x. Ann N Y Acad Sci. 2002. PMID: 12095942

2

Image processing, diagnostic information extraction and quantitative assessment in pathology.

Santinelli A, Mazzucchelli R, Colanzi P, Tinca A, Montironi R. Santinelli A, et al. Among authors: montironi r. J Cell Mol Med. 2002 Jan-Mar;6(1):93-106. doi: 10.1111/j.1582-4934.2002.tb00314.x. J Cell Mol Med. 2002. PMID: 12003672 Free PMC article.

3

Evaluation of prognostic factors in radical prostatectomy specimens with cancer.

Mazzucchelli R, Santinelli A, Lopez-Beltran A, Scarpelli M, Montironi R. Mazzucchelli R, et al. Among authors: montironi r. Urol Int. 2002;68(4):209-15. doi: 10.1159/000058437. Urol Int. 2002. PMID: 12053019 Review.

4

Improving inter-observer agreement and certainty level in diagnosing and grading papillary urothelial neoplasms: usefulness of a Bayesian belief network.

Montironi R, Mazzucchelli R, Colanzi P, Streccioni M, Scarpelli M, Thompson D, Bartels PH. Montironi R, et al. Eur Urol. 2002 Apr;41(4):449-57. doi: 10.1016/s0302-2838(02)00028-3. Eur Urol. 2002. PMID: 12074818

5

Apolipoprotein E expression in localized prostate cancers.

Venanzoni MC, Giunta S, Muraro GB, Storari L, Crescini C, Mazzucchelli R, Montironi R, Seth A. Venanzoni MC, et al. Among authors: montironi r. Int J Oncol. 2003 Apr;22(4):779-86. Int J Oncol. 2003. PMID: 12632068

6

Morphological assessment of radical prostatectomy specimens. A protocol with clinical relevance.

Montironi R, Mazzucchelli R, Kwast T. Montironi R, et al. Virchows Arch. 2003 Mar;442(3):211-7. doi: 10.1007/s00428-002-0741-7. Epub 2003 Jan 16. Virchows Arch. 2003. PMID: 12647209 Review.

7

Molecular techniques and prostate cancer diagnostic.

Montironi R, Mazzucchelli R, Scarpelli M. Montironi R, et al. Eur Urol. 2003 Oct;44(4):390-400. doi: 10.1016/s0302-2838(03)00309-9. Eur Urol. 2003. PMID: 14499671 Review.

8

Subvisual changes in chromatin organization state are detected by karyometry in the histologically normal urothelium in patients with synchronous papillary carcinoma.

Montironi R, Scarpelli M, Mazzucchelli R, Hamilton PW, Thompson D, Ranger-Moore J, Bostwick DG, Bartels PH. Montironi R, et al. Hum Pathol. 2003 Sep;34(9):893-901. doi: 10.1016/s0046-8177(03)00341-1. Hum Pathol. 2003. PMID: 14562285

9

Target populations, pathological biomarkers and chemopreventive agents in prostate cancer prevention.

Montironi R, Barbisan F, Mazzucchelli R. Montironi R, et al. Arch Ital Urol Androl. 2003 Sep;75(3):127-34. Arch Ital Urol Androl. 2003. PMID: 14661390 Review.

10

Androgen ablation therapy for prostate carcinoma suppresses the immunoreactive telomerase subunit hTERT.

Iczkowski KA, Huang W, Mazzucchelli R, Pantazis CG, Stevens GR, Montironi R. Iczkowski KA, et al. Among authors: montironi r. Cancer. 2004 Jan 15;100(2):294-9. doi: 10.1002/cncr.20002. Cancer. 2004. PMID: 14716763 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,022 results

Search Page

Filters